Adölesan Bir Annede Mortal Seyreden H1N1 Pnömoni Vakası

Yıl 2019, Cilt: 3 Sayı: 3, 255 - 259, 31.12.2019

Bahri Elmas , Onur Bircan , Mehmet Fatih Orhan , Öner Özdemir

https://doi.org/10.34084/bshr.650966

Öz

Üst ve alt solunum
yollarını tutabilen influenza A (H1N1) virüsü, viral pnömoni başta olmak üzere ağır
solunum yolu hastalıkları ve akut solunum yetmezliği sendromuna yol açabilir. İnfluenza
A virus enfeksiyonu sağlam çocuklarla birlikte komorbid hastalığı bulunan
çocuklar ve gebelik ve lohusalık gibi immünitenin baskılandığı durumlarda da
ağır enfeksiyona neden olabilmektedir. On yedi yaşında lohusalık döneminde
influenza pnömonisi nedeni ile çocuk yoğun bakım ünitesinde takip edilen
hastamız, akut solunum yetmezliği ve pulmoner kanama nedeni ile kaybedilmiştir.
Ciddi influenza enfeksiyonlarının kontrol altına alınması ve buna bağlı
ölümlerin engellenmesi için risk faktörleri iyi analiz edilip erken dönemde
koruyucu önlemler alınmalıdır.

Anahtar Kelimeler

İnfluenza A (H1N1), Lohusa, Pnömoni

A Mortal H1N1 Pneumonia Case in an Adolescent Mother

Öz

The influenza A (H1N1)
virus, which may involve the upper and lower respiratory tracts, can lead to
severe respiratory diseases, especially viral pneumonia, and acute respiratory
failure syndrome. Influenza A virus infection can cause severe infection in
healthy children, as well as children with comorbid disease and immunosuppressed conditions such as pregnancy and lactation.
A seventeen years old patient who was followed up in pediatric intensive care
unit due to influenza pneumonia during postpartum period died due to acute
respiratory failure and pulmonary hemorrhage. In order to control severe
influenza infections and prevent deaths, risk factors should be analyzed well
and preventive measures should be taken in the early period.

Anahtar Kelimeler

Influenza A (H1N1), Lactation, Pneumonia

Kaynakça

• 1. Mossad SB. The resurgence of swine-origin influenza A (H1N1). Cleve Clin J Med. 2009 Jun;76(6):337-43.
• 2. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N. Engl. J. Med. 2009; 361: 680–90.
• 3. Kinikar AA, Kulkarni RK, Valvi CT, et al. Predictors of mortality in hospitalized children with pandemic H1N1 influenza 2009 in Pune, India. Indian J Pediatr. 2012 Apr;79(4):459-66.
• 4. Shanks GD. Insights from unusual aspects of the 1918 influenza pandemic. Travel Med Infect Dis. 2015 May-Jun;13(3):217-22.
• 5. Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019 20 Influenza Season. MMWR Recomm Rep. 2019 Aug 23;68(3):1-21.
• 6. Centers for Disease Control and Prevention. Influenza antiviral medications: Summary for clinicians. https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm (Accessed on November 21, 2019).
• 7. Can Ö, Ünal N, Memikoğlu O, ve ark. Pandemik influenza A (H1N1) 2009 virüsü ve klinik tecrübemiz. Yoğun Bakım Dergisi, 2010 9(1), 1-12.
• 8. Cao B, Li XW, Mao Y, et al; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009 Dec 24;361(26):2507-17.
• 9. Bhattarai A, Villanueva J, Palekar RS, et al; Pennsylvania Working Group. Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak--Pennsylvania, May-June 2009. Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S102-8.
• 10. Viboud C, Boëlle PY, Cauchemez S, et al. Risk factors of influenza transmission in households. Br J Gen Pract. 2004 Sep;54(506):684-9.
• 11. Watanabe T. Renal complications of seasonal and pandemic influenza A virus infections. Eur J Pediatr. 2013 Jan;172(1):15-22.
• 12. Farias JA, Fernández A, Monteverde E, et al. Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina. Intensive Care Med. 2010 Jun;36(6):1015-22.
• 13. Fiore AE, Fry A, Shay D, Gubareva L, et al. Centers for Disease Control and Prevention. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2011;60(1):1–24.
• 14. Sarkar D, Sarkar S, Anand S et al. Lung protective strategy and prone ventilation resulting in successful outcome in a patient with ARDS due to H1N1. BMJ Case Rep. 2011 Feb 15;2011. pii: bcr1020103420. doi: 10.1136/bcr.10.2010.3420.
• 15. Nye S, Whitley RJ, Kong M. Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome. Front Pediatr. 2016 Nov 24;4:128. eCollection 2016.
• 16. Smalley N, MacLaren G, Best D, et al. Outcomes in children with refractory pneumonia supported with extracorporeal membrane oxygenation. Intensive Care Med. 2012 Jun;38(6):1001-7.
• 17. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA (2009) 302:1888–95.